![Mark Mossler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Mossler
No open positions remaining
Net worth: 79 551 $ as of 30/05/2026
Profile
Mark Mossler worked as Senior Director-Global Accounting at BeOne Medicines Ltd. from 2017 to 2023.
Mr. Mossler worked as Chief Accounting Officer at C4 Therapeutics, Inc. from 2023 to 2026.
Mr. Mossler completed undergraduate and MBA degrees at Babson College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/02/2026 | 18,204 ( 0.02% ) | 79 551 $ | 30/05/2026 |
Former positions of Mark Mossler
| Companies | Position | End |
|---|---|---|
| C4 THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 14/05/2026 |
| BEIGENE LTD | Comptroller/Controller/Auditor | 31/05/2023 |
Training of Mark Mossler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Mark Mossler
